The prescriber wrote it. The pharmacy ran it. The screen said "rejected," and the reason was a code nobody read aloud.

**The short answer: yes, in general. Medi-Cal's pharmacy benefit, Medi-Cal Rx, lists the common ADHD medicines on its Contract Drugs List (CDL): amphetamine mixed salts, dextroamphetamine, lisdexamfetamine, methylphenidate in several forms, dexmethylphenidate, atomoxetine, guanfacine ER and clonidine ER. Stimulants on the list are restricted to use in ADHD, every controlled-substance claim is capped at a 35-day supply, and a few products are limited to one manufacturer. Most rejections are one of those three conditions, not a coverage denial.**¹

What the Contract Drugs List says

Question What the CDL edition dated September 1, 2026 shows¹
Are stimulants covered? Yes. Amphetamine mixed salts (immediate-release tablets and extended-release capsules), dextroamphetamine, lisdexamfetamine (capsules and chewables), methylphenidate (immediate-release, extended-release tablets, CD/LA capsules, solution), dexmethylphenidate (immediate- and extended-release) and serdexmethylphenidate/dexmethylphenidate appear in the anti-hyperkinetic section.
Any restriction on stimulants? Yes. They are marked restricted to use in ADHD, under the Controlled Substance Policy.
Are non-stimulants covered? Yes. Atomoxetine, guanfacine ER and clonidine ER are listed.
How much per fill? The Controlled Substance Policy sets a maximum of 35 days' supply per claim. A prior authorization is required for claims over 35 days.
Any product limited to one maker? Yes. Lisdexamfetamine is restricted to a single NDC labeler code, and serdexmethylphenidate/dexmethylphenidate is restricted to one labeler. A generic from a different manufacturer can reject even though the drug itself is covered.

The CDL changes. Medi-Cal Rx republishes it, and the edition date on the document is the one that governs the claim.¹

Read the rejection, then act

What the pharmacy reads you Likely meaning Next move
"Not covered" or "NDC not covered" The manufacturer's product is not the listed one Ask the pharmacist to dispense the covered labeler's product, or ask the prescriber to change the product
"Days' supply exceeds limit" The prescription is written for more than 35 days Prescriber rewrites for 35 days or fewer, or files a prior authorization
"Prior authorization required" A restriction applies, or the diagnosis is not on the claim Prescriber submits the PA; Medi-Cal Rx can confirm receipt
"Refill too soon" The earlier fill has not run out by the plan's count Ask the date it can be filled; ask the prescriber if a dose change explains the gap

For any of them, call Medi-Cal Rx Customer Service at 800-977-2273, available every hour of every day, with your Medi-Cal ID and the exact drug name and strength.¹

If you are in a Medi-Cal managed care plan

Your medical care runs through the plan, but the pharmacy benefit is carved out to Medi-Cal Rx statewide, so the CDL and the 35-day rule apply regardless of which plan you have. The prescriber visit itself is the plan's responsibility, including how quickly you are seen. Does Medi-Cal cover therapy? →

Q&A

Q: Is brand-name ADHD medication covered by Medi-Cal? A: The CDL lists drugs by name and, in some cases, restricts them to a specific labeler. Whether a particular brand or generic is the covered product is a line-by-line question; the pharmacist can see it on the claim, and Medi-Cal Rx can confirm it by phone.¹

Q: Can I get a 90-day supply on Medi-Cal? A: Not without prior authorization. The 35-day cap applies to every controlled-substance claim.¹ The 90-day question in full →

Q: Does Medi-Cal pay for the ADHD evaluation too? A: A diagnostic evaluation by a Medi-Cal provider is a medical or mental-health service under your plan, separate from the pharmacy benefit. Ask your plan or clinic how adult ADHD evaluations are scheduled. Who can diagnose, and what the evaluation includes →


The seven rules between the prescription and the counter: ADHD medication in California → · When the pharmacy says no →

In crisis? Call or text 988 — free, 24/7.

Sources

  1. Medi-Cal Rx (California Department of Health Care Services), Contract Drugs List (CDL) edition dated September 1, 2026, including the Central Nervous System anti-hyperkinetic entries, the Controlled Substance Policy (35-day maximum days' supply per claim; prior authorization above 35 days), and the Customer Service Center, 800-977-2273 — medi-calrx.dhcs.ca.gov.

Paid for by participating therapists. Inclusion is computed from availability data — never purchased. No ads, no data sold.